Allergan Plc Financial Diagnostics

AGN -- USA Stock  

USD 169.22  0.13  0.08%

The current investor indifference towards the small price fluctuations of Allergan Plc could raise concerns from investors as the firm closed today at a share price of 169.22 on 1 in volume. The company executives did not add any value to Allergan Plc investors in September. However, most investors can still diversify their portfolios with Allergan Plc to hedge your portfolio against high-volatility market scenarios. The stock standard deviation of daily returns for 30 days (very short) investing horizon is currently 0.6294. The very small Stock volatility is a good signal to investors with longer term investment horizons. This diagnostics interface makes it easy to digest most current publicly released information about Allergan Plc as well as get updates on important government artifacts including earning estimates, SEC corporate filings and announcements. This module also helps to analysis Allergan Plc price relationship with some important fundamental indicators such as market cap and management efficiency. Check also Trending Equities.

Allergan Plc Note

About 89.0% of the company shares are held by institutions such as insurance companies. The company has price-to-book (P/B) ratio of 0.92. Some equities with similar Price to Book (P/B) outperform the market in the long run. Allergan Plc has Price/Earnings To Growth (PEG) ratio of 2.72. The entity recorded loss per share of 25.5. The firm last dividend was issued on 2019-08-12. Allergan Plc had 2:1 split on 1997-10-30. Allergan plc, a pharmaceutical company, develops, manufactures, and commercializes branded pharmaceutical, device, biologic, surgical, and regenerative medicine products worldwide. Allergan plc was founded in 1983 and is headquartered in Dublin, Ireland. Allergan Plc operates under Drug Manufacturers - Specialty Generic classification in USA and is traded on BATS Exchange. It employs 16900 people. For more info on ALLERGAN INC please contact Brenton Saunders at 862 261 7000 or go to http://www.allergan.com.

Allergan Plc Alerts

The company reported last year revenue of 15.68 B. Reported Net Loss for the year was (8.5 B) with profit before taxes, overhead, and interest of 13.52 B.
Over 89.0% of the company shares are held by institutions such as insurance companies
Latest headline from technewsobserver.com: Morgan Stanley Has 144.34 Million Position in Allergan plc - TechNewsObserver

Allergan Plc Upcoming and Recent Events

Upcoming Quarterly Earning ReportOctober 29, 2019
Next Earnings ReportFebruary 4, 2020
Next Fiscal Quarter EndSeptember 30, 2019
Next Fiscal Year EndFebruary 4, 2020
Last Quarter Report DateJune 30, 2019
Last Earning Anouncement DateSeptember 30, 2018

Allergan Plc Earning Estimates

EPSEstimate Date
Quarterly Estimate4.22October 29, 2019
Allergan Plc normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Allergan Plc SEC Filings

Financial Statements and Exhibits. Other Events
Financial Statements and Exhibits. Regulation FD Disclosure
Financial Statements and Exhibits. Other Events
Financial Statements and Exhibits. Results of Operations and Financial Condition
Financial Statements and Exhibits. Regulation FD Disclosure. Entry into a Material Definitive Agreement
Financial Statements and Exhibits. Results of Operations and Financial Condition
Submission of Matters to a Vote of Security Holders
Other Events

Allergan Plc Thematic Classifications

Obamacare Repeal IdeaObamacare Repeal
Large healthcare related equities associated with Obamacare
Pharmaceutical Products IdeaPharmaceutical Products
USA Equities from Pharmaceutical Products industry as classified by Fama & French
Drugs IdeaDrugs
Drug manufacturing and delivery

Institutional Investors

Security TypeSharesValue
Metropolis Capital LtdCommon Shares170.6 K28.7 M
Gulf International Bank Uk LtdCommon Shares81 K13.6 M
State Of Alaska Department Of RevenueCommon Shares72.3 K12.2 M
Havens Advisors LlcCommon Shares58.5 K9.8 M
Alpine Group Usvi LlcCommon Shares47.5 KM
Alpine Global Management LlcCommon Shares47.5 KM
Neville Rodie Shaw IncCommon Shares38.6 K6.5 M

Market Capitalization

The company currently falls under 'Large-Cap' category with total capitalization of 54.75 B.

Profitablity

The company has Net Profit Margin of (0.01) % which means that it does not effectively controls expenditures or properly executes on its pricing strategies. This is way below average. In the same way, it shows Net Operating Margin of 45.89 % which entails that for every 100 dollars of revenue it generated 0.46 of operating income.

Stock Holders for Allergan Plc

Information
Ratio
Value
At Risk
Nasdaq US Multi Cap Growth Tota 0.06 (2.73) 
NYSE(0.0136) (2.51) 
ICON Equity Income Fund Class(0.0131) (1.85) 
ClearBridge Aggressive Growth F(0.02) (2.32) 
Private Capital Management Valu(0.07) (2.19) 
Invesco Equity Weighted SP 500(0.0046) (2.68) 
Dunham Monthly Distribution Fun 0.0089 (0.24) 
Templeton World Cl R6 0.0177 (1.21) 
IVZ EUR STOXX HDLV 0.0255 (1.70) 
Templeton Growth Fund Class R(0.0003) (1.76) 
Golub Group Equity Fund(0.0131) (2.19) 
State Street Institutional Prem(0.0152) (1.63) 
NASDAQ Eurozone Ins Large Mid C 0.0489 (1.56) 
NASDAQ Europe Ins Large Mid Cap 0.12 (2.76) 
Diamond Hill Long Short Fd Cl Y 0.0178 (1.73) 
NASDAQ Netherlands Large Mid Ca 0.05 (3.30) 
NASDAQ DM Europe Ins Large Mid 0.00  0.00 
NASDAQ EMEA Ins Large Mid Cap C 0.06 (1.98) 
NASDAQ Netherlands Large Mid Ca 0.06 (2.92) 
NASDAQ Eurozone Ins Large Mid C 0.09 (2.50) 

Technical Drivers

As of 14 of October Allergan Plc shows Risk Adjusted Performance of 0.0623, Mean Deviation of 0.505 and Downside Deviation of 0.595. Allergan Plc technical analysis gives you the methodology to make use of historical prices and volume patterns to determine a pattern that approximates the direction of the firm future prices. In plain English you can use this information to find out if the firm will indeed mirror its model of historical prices and volume momentum or the prices will eventually revert. We found nineteen technical drivers for Allergan Plc which can be compared to its rivals. Please confirm Allergan Plc Information Ratio as well as the relationship between Value At Risk and Expected Short fall to decide if Allergan Plc is priced correctly providing market reflects its regular price of 169.22 per share. Given that Allergan Plc has Jensen Alpha of 0.0414, we suggest you validate Allergan Plc prevailing market performance to make sure the company can sustain itself at future point.

Allergan Plc Price Movement Analysis

Illegal number of arguments. The output start index for this execution was zero with a total number of output elements of zero. The Mid-point Price over period is an average of Allergan Plc highest and lowest prices attained during the given period. View also all equity analysis or get more info about midpoint price over period overlap studies indicator.

Allergan Plc Insider Trading Activities

Allergan Plc Outstanding Bonds

MaturityCouponRating
018490AM4 5.75%04/01/20165.75
A+
018490AN2 3.375%09/15/20203.375
A+
018490AP7 1.35%03/15/20181.35
A+
018490AQ5 2.8%03/15/20232.8
A+

Allergan Plc Predictive Indicators

Allergan Plc Forecast Models

Recommendations

Allergan Plc Analyst Recommendations

Target PriceAdvice# of Analysts
186.28Hold18Odds
Allergan Plc current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Allergan Plc Analyst Advice  

Vital Value Indicators

Allergan Plc Basic Pricing Drivers

Quick Ratio0.61
Fifty Two Week Low114.27
Trailing Annual Dividend Rate2.92
Revenue Growth-0.80%
Shares Short Prior Month5.09M
Average Daily Volume Last 10 Day2M
Average Daily Volume In Three Month3.79M
Shares Percent Shares Out2.21%
Gross Margins85.56%
Short Percent Of Float2.20%
Forward Price Earnings9.92
Float Shares327.5M
Fifty Two Week High193.44
Enterprise Value To Ebitda10.64
Fifty Day Average163.74
Two Hundred Day Average151.01
Trailing Annual Dividend Yield1.73%
Enterprise Value To Revenue4.88
Check also Trending Equities. Please also try Correlation Analysis module to reduce portfolio risk simply by holding instruments which are not perfectly correlated.
Search macroaxis.com